Hey Guys,
Thought I'd start a new thread on stem-cell therapy milestones. For me the regulatory landscape made a significant shift with COVID-19 stem-cell treatments being included in FDA trials (see other threads to gauge how the FDA is engaging properly trialed stem-cell therapies). To me this all changes the wider environment for acceptance of stem-cell treatments including OCC's ATI treatment, the obvious gold-star treatment for degenerative tendons. Presumably many of you will be interested in general stem-cell therapies on a wider front. Another recent milestone:
https://medicalxpress.com/news/2020-05-japan-newborn-liver-stem-cells.html
Stem-cell treatment in a newborn is really breaking conservative boundaries in medicine....
-
- There are more pages in this discussion • 432 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.020(1.57%) |
Mkt cap ! $312.1M | |||
| Open | High | Low | Value | Volume |
| $1.28 | $1.28 | $1.25 | $22.07K | 17.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 23608 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 1301 | 1 |
View Market Depth
| Last trade - 10.03am 01/08/2025 (20 minute delay) ? |
| OCC (ASX) Chart |